YOGULACT-PEDIATRIC
Natural health product licensed in Canada
- Licence holder
- Pharmascience Inc. / Pendopharms, Division of Pharmascience Inc.
- NPN or DIN-HM
- 80026435
- Status
- Active licence
- Licence date
- 19 July 2011
- Revision date
- 14 May 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : HA-122 | 0.05 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : HA-122 | 0.38 mg | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 0.05 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 0.38 mg | Not calculated |
| Lactobacillus rhamnosus Source : En entier | 0.91 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Lactobacillus rhamnosus | 0.91 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : HA-111 | 0.91 Milliards d'UFC | Not calculated |
| Streptococcus salivarius subsp. thermophilus Source : Streptococcus salivarius subsp. thermophilus- Whole | 0.21 mg | Not calculated |
| Streptococcus salivarius subsp. thermophilus Source : Streptococcus salivarius subsp. thermophilus- Whole | 0.03 Milliards d'UFC | Not calculated |
| Streptococcus salivarius subsp. thermophilus Source : HA-110 | 0.21 mg | Not calculated |
| Streptococcus salivarius subsp. thermophilus Source : HA-110 | 0.03 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Lactose, FD&C Yellow 6, Acide ascorbique, Rouge FD&C no 40
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 1 year ; maximum: 6 years | 1 Capsule | 2 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 14 years | minimum: 1 Capsule ; maximum: 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Probiotic that contributes to a natural healthy gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain. Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
Source
Official Health Canada record, licence 80026435
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging